Mettler-Toledo International, Inc. (NYSE:MTD) Receives Average Recommendation of “Hold” from Brokerages

Shares of Mettler-Toledo International, Inc. (NYSE:MTD) have earned an average rating of “Hold” from the twelve ratings firms that are currently covering the firm, MarketBeat Ratings reports. Seven analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $1,406.50.

MTD has been the subject of a number of research analyst reports. Bank of America boosted their price target on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a report on Monday, September 22nd. Evercore ISI boosted their target price on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 7th. JPMorgan Chase & Co. raised their price target on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research note on Thursday, October 9th. Stifel Nicolaus lifted their price target on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a report on Monday. Finally, Citigroup increased their price objective on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a research note on Monday.

Insider Activity

In related news, Director Thomas P. Salice sold 1,062 shares of the firm’s stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the sale, the director owned 283 shares of the company’s stock, valued at $368,154.70. This trade represents a 78.96% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Shawn Vadala sold 300 shares of the business’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total value of $397,500.00. Following the sale, the chief financial officer owned 5,095 shares in the company, valued at $6,750,875. This represents a 5.56% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 1,527 shares of company stock worth $1,994,981. Insiders own 1.94% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in MTD. MAI Capital Management lifted its stake in shares of Mettler-Toledo International by 30.2% in the third quarter. MAI Capital Management now owns 138 shares of the medical instruments supplier’s stock worth $169,000 after acquiring an additional 32 shares during the period. Bradley Foster & Sargent Inc. CT lifted its position in shares of Mettler-Toledo International by 3.7% in the 3rd quarter. Bradley Foster & Sargent Inc. CT now owns 1,634 shares of the medical instruments supplier’s stock worth $2,006,000 after purchasing an additional 59 shares during the period. Mufg Securities Americas Inc. boosted its stake in shares of Mettler-Toledo International by 20.6% in the 3rd quarter. Mufg Securities Americas Inc. now owns 556 shares of the medical instruments supplier’s stock valued at $683,000 after purchasing an additional 95 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Mettler-Toledo International by 2.4% during the third quarter. EverSource Wealth Advisors LLC now owns 294 shares of the medical instruments supplier’s stock worth $361,000 after buying an additional 7 shares during the period. Finally, Transatlantique Private Wealth LLC raised its stake in Mettler-Toledo International by 32.7% during the third quarter. Transatlantique Private Wealth LLC now owns 296 shares of the medical instruments supplier’s stock worth $363,000 after buying an additional 73 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Trading Down 0.4%

Shares of Mettler-Toledo International stock opened at $1,433.54 on Tuesday. The company has a market cap of $29.53 billion, a PE ratio of 36.30, a price-to-earnings-growth ratio of 4.19 and a beta of 1.41. The company has a 50 day moving average of $1,323.11 and a 200-day moving average of $1,240.69. Mettler-Toledo International has a 1-year low of $946.69 and a 1-year high of $1,454.68.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $997.36 million. During the same period last year, the firm posted $10.21 earnings per share. The firm’s quarterly revenue was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. Research analysts forecast that Mettler-Toledo International will post 42.71 earnings per share for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.